A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment Jean-Eric TarrideRobert HopkinsRon Goeree Review Article 29 September 2012 Pages: 255 - 277
Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis William A. Prescott JrFred DolorescoJoseph A. Paladino Review Article 29 September 2012 Pages: 279 - 293
Does the Funding Source Influence the Results in Economic Evaluations? Rachael L. FleurenceD. Eldon SpackmanChristopher Hollenbeak Original Research Article 29 September 2012 Pages: 295 - 306
Pharmacoeconomic Evaluation in Ireland Lesley TilsonAisling O’LearyMichael Barry Original Research Article 29 September 2012 Pages: 307 - 322
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis Jeroen P. JansenSabine GaugrisWiro Stam Original Research Article 29 September 2012 Pages: 323 - 344
Towards More Consistent Use of Generic Quality-of-Life Instruments Mattias Neyt Correspondence 29 September 2012 Pages: 345 - 346